Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 4179-4181

  Mahady, G B ^a   Pendland, S L ^a   Yun, G ^a   Lu, Z Z ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemoprevention; Curcuma longa; Curcumin; Helicobacter pylori; Turmeric

Indexed keywords

AMOXICILLIN; CAGA PROTEIN; CARCINOGEN; CURCUMA LONGA EXTRACT; CURCUMIN; METHANOL;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CHEMOPROPHYLAXIS; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRY POWDER; GROWTH INHIBITION; HELICOBACTER PYLORI; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RHIZOME; STOMACH CANCER;

CURCUMA; CURCUMIN; HELICOBACTER PYLORI; METHANOL; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS;

EID: 0036875379     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Parsonnet J: Bacterial infection as a cause of cancer. Environ Health Perspect 103 Suppl 8: 263-268, 1995.
2. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, and Goebell H: Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 60: 210-215, 1999.
3. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E,and de Franchis R: High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 25: 605-607, 2001.
4. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Schistomsomes, Liver Flukes and Helicobacter pylori. Infections with Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61. Lyon, France: International Agency for Research on Cancer. 1994, pp 177-201.
5. Scheiman JM and Cutler AF: Helicobacter pylori and gastric cancer. Am J Med 106: 222-226, 1999.
6. Kim JM, Araki S, Kim DJ, Park CB, Takasuka N, Baba-Toriyama H, Ota T, Nir Z, Khachik F, Shimidu N, Tanaka Y, Osawa T, Uraji T, Murakoshi M, Nishino H and Tsuda H: Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogensis after 1,2-dimethylhydrazine initiation. Carcinogensis 19: 81-85, 1998.
7. Rao CV, Rivenson A, Simi B and Reddy BS: Chemoprevention of colon carcinogensis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55: 259-266, 1995.
8. Singh SV, Hu X, Srivastava SK, Singh M, Xia H, Orchard JL and Zaren HA: Mechanism of inhibition of benxo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogensis 19: 1357-1360, 1998.
9. Govindrajin VS: Turmeric chemistry, technology and quality. CRC Reviews in Food Science and Nutrition 12: 199-201, 1980.
10. Peek RM, Wirth HP, Moss SF, Yang MQ, Abdalla AM, Tham KT, Zhang T, Tang LH, Modlin IM and Blaser MJ: Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 118: 48-59, 2000.
11. Zhao DY and Yang MK: Separation and determination of curcuminoids in Curcuma longa L. and its preparation by HPLC. Yao Hsueh Hsueh Pao 21: 382-385, 1986.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - fourth edition; Approved standard. NCCLS document M7-A4, vol. 17, no. 2. National Committee for Clinical Laboratory Standards, Wayne, PA, 1997.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Ninth informational supplement. NCCLS document M100-S9, vol. 19, no. 1. National Committee for Clinical Laboratory Standards, Wayne, PA, 1999.
14. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CVand Reddy BS: Chemopreventative effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer, Cancer Res 59: 597-601, 1999.
15. Gescher A J, Sharma RA and Steward WP: Cancer chemoprevention by dietary, constituents: a tale of failure and promise. Lancet Oncol 2: 371-379, 2001.
16. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R and Covacci A: Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease associated virulence factors. Proc Natl Acad Sci USA 93: 14648-14653, 1996.